Diagnostic Criteria for Obstructive Sleep Apnea (OSA)
The diagnosis of OSA requires both clinical symptoms AND polysomnographic evidence of ≥5 respiratory events per hour of sleep, with appropriate testing determined by patient risk factors and comorbidities. 1
Clinical Criteria
The clinical diagnosis requires:
Primary Symptom:
OR at least two of the following symptoms:
- Choking or gasping during sleep
- Recurrent awakenings from sleep
- Unrefreshing sleep
- Daytime fatigue
- Impaired concentration 2
Polysomnographic Criteria
The objective diagnosis requires:
- ≥5 obstructive respiratory events per hour of sleep 1, 2
- Respiratory events defined as:
- Apnea: Complete absence of airflow for ≥10 seconds with continued respiratory effort
- Hypopnea: Reduction in airflow of ≥30% for ≥10 seconds associated with either:
- ≥3% oxygen desaturation OR
- An electroencephalographic arousal 1
Severity Classification
OSA severity is classified by the Apnea-Hypopnea Index (AHI):
- Mild: 5-15 events per hour
- Moderate: 15-30 events per hour
- Severe: ≥30 events per hour 1
Diagnostic Testing Algorithm
Initial Assessment for OSA Risk:
- Evaluate for excessive daytime sleepiness AND at least two of:
- Habitual loud snoring
- Witnessed apnea or gasping/choking
- Diagnosed hypertension 3
- Evaluate for excessive daytime sleepiness AND at least two of:
Testing Selection:
A. Home Sleep Apnea Testing (HSAT) is appropriate when:
- Patient has increased risk of moderate to severe OSA
- Patient has no significant comorbidities
- Device must include minimum of:
B. In-laboratory Polysomnography (PSG) is required when:
- Patient has significant cardiopulmonary disease
- Potential respiratory muscle weakness due to neuromuscular condition
- History of stroke
- Chronic opioid medication use
- Severe insomnia
- Symptoms of other significant sleep disorders
- Environmental or personal factors that preclude adequate HSAT
- Previous HSAT was negative, inconclusive, or technically inadequate 3, 1
Technical Requirements:
Important Considerations
Clinical tools, questionnaires, and prediction algorithms alone should NOT be used to diagnose OSA in the absence of PSG or HSAT 3
The correlation between AHI and daytime symptoms is often weak, with significant interindividual variability in symptom presentation 2
Prevalence of OSA (AHI ≥5/hr) is approximately 17% in women and 34% in men, though many are asymptomatic 4
OSA is associated with 2-3 fold increased risk of cardiovascular and metabolic disease, making accurate diagnosis crucial 4
In non-obese patients (BMI <30), specific anatomical factors like craniofacial abnormalities and retrognathia may be more significant contributors to OSA 5
Follow-up should occur early after diagnosis and treatment initiation to ensure adherence 1